This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. AbstractBackground: Dupilumab, a fully human monoclonal antibody that binds IL-4Rα and inhibits signaling of both IL-4 and IL-13, has shown efficacy across multiple diseases with underlying type 2 signatures and is approved for treatment of asthma, atopic dermatitis, and chronic sinusitis with nasal polyposis. We sought to provide a comprehensive analysis of the redundant and distinct roles of IL-4 and IL-13 in type 2 inflammation and report dupilumab mechanisms of action.Methods: Using primary cell assays and a mouse model of house dust mite-induced asthma, we compared IL-4 vs IL-13 vs IL-4Rα blockers.Results: Intranasal administration of either IL-4 or IL-13 confers an asthma-like phenotype in mice by inducing immune cell lung infiltration, including eosinophils, increasing cytokine/chemokine expression and mucus production, thus demonstrating redundant functions of these cytokines. We further teased out their respective contributions using human in vitro culture systems. Then, in a mouse asthma model by comparing in head-to-head studies, either IL-4 or IL-13 inhibition to dual IL-4/ IL-13 inhibition, we demonstrate that blockade of both IL-4 and IL-13 is required to broadly block type 2 inflammation, which translates to protection from allergeninduced lung function impairment. Notably, only dual IL-4/IL-13 blockade prevented eosinophil infiltration into lung tissue without affecting circulating eosinophils, demonstrating that tissue, but not circulating eosinophils, contributes to disease pathology.

Sepsis in the UnitedStates has an estimated annual healthcare cost of $16.7 billion and leads to 120 000 deaths. Insufficient development in both medical diagnosis and treatment of sepsis has led to continued growth in reported cases of sepsis over the past two decades with little improvement in mortality statistics. Efforts over the last decade to improve diagnosis have unsuccessfully sought to identify a "magic bullet" proteic biomarker that provides high sensitivity and specificity for infectious inflammation. More recently, genetic methods have made tracking regulation of the genes responsible for these biomarkers possible, giving current research new direction in the search to understand how host immune response combats infection. Despite the breadth of research, inadequate treatment as a result of delayed diagnosis continues to affect approximately one fourth of septic patients. In this report we review past and present diagnostic methods for sepsis and their respective limitations, and discuss the requirements for more timely diagnosis as the next step in curtailing sepsis-related mortality. We also present a proposal toward revision of the current diagnostic paradigm to include real-time immune monitoring.

are employees and shareholders of Regeneron Pharmaceuticals. J. S. Erjef€ alt and C. Sand en are employees of Medetect AB.

This report presents the development of pre-cross-linked and in situ cross-linked polyethyleneimine-carboxymethylcellulose antibody immobilization platforms for real-time QCM-D immunoassay of sepsis-related biomarkers. These platforms differ significantly from recent trends in QCM-based assays, a rapidly expanding field given the affordability and sensitivity of the transduction system, by providing ultrafast biointerface deposition through cross-linking of polysaccharides. Using rhIL-1ra (17 kDa), a known sepsis biomarker, for development, various immunoassay modifications to increase sensitivity were investigated, including the use of Protein A, Protein G, and anti-IgG Fc specific antibody capture ligands for oriented antibody immobilization, higher-frequency QCM-D crystals, and amplification using secondary antibodies. The optimized assay employs Protein A oriented immobilization on pre-cross-linked polymer and secondary antibodies to achieve a detection limit of 25 ng/mL on 5 MHz crystals. Assay repeatability using the optimized chemistry is robust, with no loss in 100 ng/mL antigen detection over 20 cycles of the 10 min sandwich assay. Nonspecific adsorption of human serum albumin, as characterized by ToF-SIMS, is minimal and negligible for the pre-cross-linked and in situ cross-linked compositions, respectively.

To cite this article: George M. Scott (1990) A resynthesis of the primordial and circumstantial approaches to ethnic group solidarity: Towards an explanatory model, Ethnic and Racial Studies, 13:2, 147-171, AbstractSocial scientists who have attempted to explain ethnic group solidarity have tended to use either the primordial or the circumstantial approach. The first approach accounts for strong ethnic attachments on the basis of their ineffable affective significance. Moreover, this affective significance most often surrounds images of the group's distinctive past, thus giving a historical dimension to the concept of primordialism. The second approach views ethnic group solidarity as resulting from certain social circumstances, both internal and external, under which the members of the group exist. It is argued that neither approach alone offers a sufficient explanation -i.e., that the primordial approach cannot readily account for fluctuating ethnic group solidarity and that the circumstantial approach tends to ignore the affective significance of ethnic ties -and that previous attempts to synthesize them have been inadequate as explanatory models. Such a synthetic model is offered, which is based on the oppositional approach originated by Edward Spicer and which maintains that fluctuating ethnicity, along with fluctuating primordial sentiments, can be best explained on the basis of the circumstance of fluctuating opposition.

This article reports the results of a study of management of technology issues (unresolved technology management problems) in the new product development (NPD) processes of high‐tech product companies. Using a three‐questionnaire DELPHI methodology that includes academic and industry participants, the study ranks 24 technology management issues of NPD in terms of importance. A dominant “Number One Issue” is identified as Strategic Planning for Technology Products.

No abstract

No abstract